Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 34EISAI INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 9006256

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-1695

Delist Requested :

Patent Use Description : METHOD FOR TREATING TH...

Patent Expiration Date : 2027-07-27

blank

02

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

blank

03

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

blank

04

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3997

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

blank

05

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12083112

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3997

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-03

blank

06

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 11090386

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3519

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-23

blank

07

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 11090386

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-3519

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-23

blank

08

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12226409

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-4146

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-05-15

blank

09

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 12226409

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-4146

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-05-15

blank

10

arrow
German Wound Congress
Not Confirmed
arrow
German Wound Congress
Not Confirmed

LENVATINIB MESYLATE

US Patent Number : 9006256

Drug Substance Claim :

Drug Product Claim :

Application Number : 206947

Patent Use Code : U-1695

Delist Requested :

Patent Use Description : METHOD FOR TREATING TH...

Patent Expiration Date : 2027-07-27

blank